Congratulations to our PharmD students, Michael Sporck, ‘20, Eunice Kim, ‘20, Hanna Kleiboeker, ‘20 and Erin Ichinotsubo, ‘21, who won first place at the highly competitive Academy of Managed Care Pharmacy (AMCP) Foundation 19th Annual National Student Pharmacist Pharmacy & Therapeutics (P&T) Competition. The team’s advisors were UWSOP faculty David Veenstra and Pete Fullerton. John Watkins of Premera served as their external advisor.
“We are extraordinarily proud of Erin, Eunice, Hanna, and Michael for their win at this year’s National AMCP P&T competition. The National P&T is one of the toughest competitions student pharmacists can go through. After months of studying and hard work, the team emerged at the top of a record number of competitors. Congratulations to the team on their outstanding achievement and our thanks to their advisors, Dave, Pete, and John for supporting the team.”—Sean D. Sullivan, Professor and Dean, UWSOP
The Competition is an annual team event that provides an immersive experience in effective formulary review and management. The awards were presented March 28 at the AMCP Foundation Awards Ceremony, held during the AMCP Managed Care & Specialty Pharmacy Annual Meeting in San Diego, California.
This year the competition was exceptional with a record 67 schools of pharmacy nationwide participated in the Competition. Eight national finalists advanced to the live finals, where a panel of judges simulated a P&T Committee on March 26 at the AMCP Annual Meeting.
“The effort and energy invested by all of our competitors was evident in the depth of reasoning and professionalism displayed locally and at the national finals,” said Paula J. Eichenbrenner, MBA, CAE, AMCP Foundation Executive Director. “Competitors were supported in this rigorous journey by many dedicated faculty advisors, Competition coordinators, AMCP student chapter leaders, and volunteer judges.”
P&T Competition teams work through a case study using a product dossier in the AMCP Format for Formulary Submissions. Students evaluate the body of evidence on the study drug and comparators, assess value, and develop a monograph as they determine a recommendation for formulary placement and prepare an oral summary.
The study drug for the 2019 P&T Competition was TYMLOS® (abaloparatide) injection, indicated for the treatment of postmenopausal women with osteoporosis at high risk for fracture. The AMCP Foundation thanked manufacturer Radius Health, Inc., for facilitating use of this dossier and Dymaxium for hosting the Competition platform on AMCP eDossier.
Are you interested in working with the top-rated faculty and studying pharmacy with preeminent student peers?
Click here for more information about our UW PharmD program.